huahaipharm(SH:600521) Xin Lang Cai Jing·2025-08-26 01:38Group 1 - Huahai Pharmaceutical (600521.SH) released its semi-annual report for 2025, showing that as of August 25, 2025, 31 institutional investors disclosed holding A-shares, totaling 144 million shares, which accounts for 9.62% of the total share capital [1] - The top ten institutional investors collectively hold 9.24% of the shares, with a 0.69 percentage point increase compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, including China Europe Medical Health Mixed A and Southern CSI 500 ETF, with an increase ratio of 0.96% [2] - Two public funds decreased their holdings, namely Anxin Medical Health Stock A and Industrial Bank Medical Care A, with a decrease ratio of 0.19% [2] - A total of 22 new public funds were disclosed this period, including Guangda Baodexin Health Superior Mixed A and Huazhang Medical Innovation Mixed A [2] - One social security fund increased its holdings, specifically Guotai Fund Management Co., Ltd. - Social Security Fund 2103 Combination, with an increase ratio of 0.27% [2]